glp 1 non alcoholic fatty liver Effects of GLP-1 receptor agonists on the degree of fibrosis and CRP in non-alcoholic liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis Does GLP-1 Help Fatty Liver?

This section will briefly review what we know about the current safety data of GLP-1 and GLP-1/GIP agonists, and factors that may promote long term clinical use of these agents in obesity

Dehydrocorydaline Attenuates Bone Cancer Pain by Shifting Microglial M1/M2 Polarization toward the M2 Phenotype

TB-500 Highlights

Many patients experience needle fatigue or outright refuse therapy, resulting in poor adherence and suboptimal clinical outcomes

Notably, no significant correlation was observed between the duration of GLP-1RAs discontinuation and the prevalence of retained gastric contents, although a trend toward reduced retention with longer discontinuation was noted